Report Detail

Pharma & Healthcare Global Cystic Fibrosis Drugs Market Professional Survey Report 2019

  • RnM2771886
  • |
  • 15 January, 2019
  • |
  • Global
  • |
  • 121 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Cystic Fibrosis Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Cystic Fibrosis Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cystic Fibrosis Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cystic Fibrosis Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cystic Fibrosis Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Actavis
F. Hoffmann-La Roche
Gilead Sciences
Novartis
Vertex Pharmaceuticals
Abbott
Anthera Pharmaceuticals
Arcturus Therapeutics
Boehringer Ingelheim
Chiesi Farmaceutici
Corbus Pharmaceuticals
Genzyme
Insmed
Johnson & Johnson
Merck Sharp & Dohme
Neovii Biotech
Novo Nordisk
PharmaSwiss
Pharmaxis
Proteostasis Therapeutics
PTC Therapeutics
United Medical
Venus Remedies

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Oral
Injection

Segment by Application
Hospitals
Clinics
Other


Table of Contents

    Executive Summary

      1 Industry Overview of Cystic Fibrosis Drugs

      • 1.1 Definition of Cystic Fibrosis Drugs
      • 1.2 Cystic Fibrosis Drugs Segment by Type
        • 1.2.1 Global Cystic Fibrosis Drugs Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Oral
        • 1.2.3 Injection
      • 1.3 Cystic Fibrosis Drugs Segment by Applications
        • 1.3.1 Global Cystic Fibrosis Drugs Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinics
        • 1.3.4 Other
      • 1.4 Global Cystic Fibrosis Drugs Overall Market
        • 1.4.1 Global Cystic Fibrosis Drugs Revenue (2014-2025)
        • 1.4.2 Global Cystic Fibrosis Drugs Production (2014-2025)
        • 1.4.3 North America Cystic Fibrosis Drugs Status and Prospect (2014-2025)
        • 1.4.4 Europe Cystic Fibrosis Drugs Status and Prospect (2014-2025)
        • 1.4.5 China Cystic Fibrosis Drugs Status and Prospect (2014-2025)
        • 1.4.6 Japan Cystic Fibrosis Drugs Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Cystic Fibrosis Drugs Status and Prospect (2014-2025)
        • 1.4.8 India Cystic Fibrosis Drugs Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Cystic Fibrosis Drugs
      • 2.3 Manufacturing Process Analysis of Cystic Fibrosis Drugs
      • 2.4 Industry Chain Structure of Cystic Fibrosis Drugs

      3 Development and Manufacturing Plants Analysis of Cystic Fibrosis Drugs

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Cystic Fibrosis Drugs Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Cystic Fibrosis Drugs
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Cystic Fibrosis Drugs Production and Capacity Analysis
      • 4.2 Cystic Fibrosis Drugs Revenue Analysis
      • 4.3 Cystic Fibrosis Drugs Price Analysis
      • 4.4 Market Concentration Degree

      5 Cystic Fibrosis Drugs Regional Market Analysis

      • 5.1 Cystic Fibrosis Drugs Production by Regions
        • 5.1.1 Global Cystic Fibrosis Drugs Production by Regions
        • 5.1.2 Global Cystic Fibrosis Drugs Revenue by Regions
      • 5.2 Cystic Fibrosis Drugs Consumption by Regions
      • 5.3 North America Cystic Fibrosis Drugs Market Analysis
        • 5.3.1 North America Cystic Fibrosis Drugs Production
        • 5.3.2 North America Cystic Fibrosis Drugs Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Cystic Fibrosis Drugs Import and Export
      • 5.4 Europe Cystic Fibrosis Drugs Market Analysis
        • 5.4.1 Europe Cystic Fibrosis Drugs Production
        • 5.4.2 Europe Cystic Fibrosis Drugs Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Cystic Fibrosis Drugs Import and Export
      • 5.5 China Cystic Fibrosis Drugs Market Analysis
        • 5.5.1 China Cystic Fibrosis Drugs Production
        • 5.5.2 China Cystic Fibrosis Drugs Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Cystic Fibrosis Drugs Import and Export
      • 5.6 Japan Cystic Fibrosis Drugs Market Analysis
        • 5.6.1 Japan Cystic Fibrosis Drugs Production
        • 5.6.2 Japan Cystic Fibrosis Drugs Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Cystic Fibrosis Drugs Import and Export
      • 5.7 Southeast Asia Cystic Fibrosis Drugs Market Analysis
        • 5.7.1 Southeast Asia Cystic Fibrosis Drugs Production
        • 5.7.2 Southeast Asia Cystic Fibrosis Drugs Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Cystic Fibrosis Drugs Import and Export
      • 5.8 India Cystic Fibrosis Drugs Market Analysis
        • 5.8.1 India Cystic Fibrosis Drugs Production
        • 5.8.2 India Cystic Fibrosis Drugs Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Cystic Fibrosis Drugs Import and Export

      6 Cystic Fibrosis Drugs Segment Market Analysis (by Type)

      • 6.1 Global Cystic Fibrosis Drugs Production by Type
      • 6.2 Global Cystic Fibrosis Drugs Revenue by Type
      • 6.3 Cystic Fibrosis Drugs Price by Type

      7 Cystic Fibrosis Drugs Segment Market Analysis (by Application)

      • 7.1 Global Cystic Fibrosis Drugs Consumption by Application
      • 7.2 Global Cystic Fibrosis Drugs Consumption Market Share by Application (2014-2019)

      8 Cystic Fibrosis Drugs Major Manufacturers Analysis

      • 8.1 Actavis
        • 8.1.1 Actavis Cystic Fibrosis Drugs Production Sites and Area Served
        • 8.1.2 Actavis Product Introduction, Application and Specification
        • 8.1.3 Actavis Cystic Fibrosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 F. Hoffmann-La Roche
        • 8.2.1 F. Hoffmann-La Roche Cystic Fibrosis Drugs Production Sites and Area Served
        • 8.2.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
        • 8.2.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Gilead Sciences
        • 8.3.1 Gilead Sciences Cystic Fibrosis Drugs Production Sites and Area Served
        • 8.3.2 Gilead Sciences Product Introduction, Application and Specification
        • 8.3.3 Gilead Sciences Cystic Fibrosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Novartis
        • 8.4.1 Novartis Cystic Fibrosis Drugs Production Sites and Area Served
        • 8.4.2 Novartis Product Introduction, Application and Specification
        • 8.4.3 Novartis Cystic Fibrosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Vertex Pharmaceuticals
        • 8.5.1 Vertex Pharmaceuticals Cystic Fibrosis Drugs Production Sites and Area Served
        • 8.5.2 Vertex Pharmaceuticals Product Introduction, Application and Specification
        • 8.5.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Abbott
        • 8.6.1 Abbott Cystic Fibrosis Drugs Production Sites and Area Served
        • 8.6.2 Abbott Product Introduction, Application and Specification
        • 8.6.3 Abbott Cystic Fibrosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Anthera Pharmaceuticals
        • 8.7.1 Anthera Pharmaceuticals Cystic Fibrosis Drugs Production Sites and Area Served
        • 8.7.2 Anthera Pharmaceuticals Product Introduction, Application and Specification
        • 8.7.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Arcturus Therapeutics
        • 8.8.1 Arcturus Therapeutics Cystic Fibrosis Drugs Production Sites and Area Served
        • 8.8.2 Arcturus Therapeutics Product Introduction, Application and Specification
        • 8.8.3 Arcturus Therapeutics Cystic Fibrosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Boehringer Ingelheim
        • 8.9.1 Boehringer Ingelheim Cystic Fibrosis Drugs Production Sites and Area Served
        • 8.9.2 Boehringer Ingelheim Product Introduction, Application and Specification
        • 8.9.3 Boehringer Ingelheim Cystic Fibrosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Chiesi Farmaceutici
        • 8.10.1 Chiesi Farmaceutici Cystic Fibrosis Drugs Production Sites and Area Served
        • 8.10.2 Chiesi Farmaceutici Product Introduction, Application and Specification
        • 8.10.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Corbus Pharmaceuticals
      • 8.12 Genzyme
      • 8.13 Insmed
      • 8.14 Johnson & Johnson
      • 8.15 Merck Sharp & Dohme
      • 8.16 Neovii Biotech
      • 8.17 Novo Nordisk
      • 8.18 PharmaSwiss
      • 8.19 Pharmaxis
      • 8.20 Proteostasis Therapeutics
      • 8.21 PTC Therapeutics
      • 8.22 United Medical
      • 8.23 Venus Remedies

      9 Development Trend of Analysis of Cystic Fibrosis Drugs Market

      • 9.1 Global Cystic Fibrosis Drugs Market Trend Analysis
        • 9.1.1 Global Cystic Fibrosis Drugs Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Cystic Fibrosis Drugs Regional Market Trend
        • 9.2.1 North America Cystic Fibrosis Drugs Forecast 2019-2025
        • 9.2.2 Europe Cystic Fibrosis Drugs Forecast 2019-2025
        • 9.2.3 China Cystic Fibrosis Drugs Forecast 2019-2025
        • 9.2.4 Japan Cystic Fibrosis Drugs Forecast 2019-2025
        • 9.2.5 Southeast Asia Cystic Fibrosis Drugs Forecast 2019-2025
        • 9.2.6 India Cystic Fibrosis Drugs Forecast 2019-2025
      • 9.3 Cystic Fibrosis Drugs Market Trend (Product Type)
      • 9.4 Cystic Fibrosis Drugs Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Cystic Fibrosis Drugs Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Cystic Fibrosis Drugs . Industry analysis & Market Report on Cystic Fibrosis Drugs is a syndicated market report, published as Global Cystic Fibrosis Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Cystic Fibrosis Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,705.50
        4,058.25
        5,411.00
        3,258.50
        4,887.75
        6,517.00
        534,415.00
        801,622.50
        1,068,830.00
        295,400.00
        443,100.00
        590,800.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report